| Company Name: |
Energy Chemical
|
| Tel: |
021-58432009 400-005-6266 |
| Email: |
marketing@energy-chemical.com |
| Products Intro: |
Product Name:3β-17-Imino-androst-5-en-3-ol Dimer
CAS:491873-45-1
Purity:NULL Package:100mg;1g Remarks:NULL
|
| Company Name: |
Cato Research Chemicals Inc.
|
| Tel: |
020-81960175-877 18933936954 |
| Email: |
tianwen.zhan@cato-chem.com |
| Products Intro: |
Product Name:Abiraterone Impurity 40
CAS:491873-45-1
Purity:>95% Package:10mg
|
| Company Name: |
SynZeal Research Pvt Ltd
|
| Tel: |
+1 226-802-2078 |
| Email: |
standards@synzeal.com |
| Products Intro: |
Product Name:3β-17-Imino-androst-5-en-3-ol Dimer
CAS:491873-45-1
|
| Company Name: |
Pharma Affiliates
|
| Tel: |
172-5066494 |
| Email: |
@pharmaffiliates.com |
| Products Intro: |
Product Name:3β-17-Imino-androst-5-en-3-ol Dimer
CAS:491873-45-1
|
|
| | 3β-17-Imino-androst-5-en-3-ol Dimer Basic information |
| Product Name: | 3β-17-Imino-androst-5-en-3-ol Dimer | | Synonyms: | 3β-17-Imino-androst-5-en-3-ol Dimer;Abiraterone Impurity 10Q: What is
Abiraterone Impurity 10 Q: What is the CAS Number of
Abiraterone Impurity 10;3β-17-Imino-androst-5-en-3-ol dimer;Androst-5-en-17-one, 3-hydroxy-, 2-[(3β)-3-hydroxyandrost-5-en-17-ylidene]hydrazone, (3β)- | | CAS: | 491873-45-1 | | MF: | C38H56N2O2 | | MW: | 572.88 | | EINECS: | | | Product Categories: | | | Mol File: | 491873-45-1.mol |  |
| | 3β-17-Imino-androst-5-en-3-ol Dimer Chemical Properties |
| Melting point | >251°C (dec.) | | Boiling point | 686.5±55.0 °C(Predicted) | | density | 1.31±0.1 g/cm3(Predicted) | | storage temp. | -20°C Freezer, Under inert atmosphere | | solubility | Chloroform (Slightly, Heated) | | form | Solid | | pka | 14.71±0.60(Predicted) | | color | White to Off-White |
| | 3β-17-Imino-androst-5-en-3-ol Dimer Usage And Synthesis |
| Uses | 3β-17-Imino-androst-5-en-3-ol Dimer is an impurity of Abiraterone (A108490), a steroidal cytochrome P 450 17α-hydroxylase-17,20-lyase inhibitor (CYP17). Abiraterone is currently undergoing phase II clinical trials as a potential drug for the treatment of androgen-dependent prostate cancer. |
| | 3β-17-Imino-androst-5-en-3-ol Dimer Preparation Products And Raw materials |
|